Drug Trial Radar · NCT07354724
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
32
Planned (sponsor's estimate)
Start
May 12, 2026
Primary completion
Aug 2028
Study completion Aug 2028
Sponsor
- Lead sponsor
- Denali Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 21, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 1/2, multicenter, open-label study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of DNL952 in adult participants with late-onset Pompe disease. The principal aim of this study is to obtain safety and tolerability data across various dose levels of DNL952 in participants with late-onset Pompe disease (LOPD).
Conditions
- Late-onset Pompe Disease
Interventions
DNL952Drug
Intravenous repeating dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence, severity, and seriousness of treatment-emergent adverse events (TEAEs)Time frame: 48 weeks
- Incidence and severity of infusion-related reacations (IRRs)Time frame: 48 weeks
Locations
8 sites in 4 countries. Site status is shown where the registry gives one.
University of California-Irvine
Irvine, California · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Duke University School of Medicine - Early Phase Research Unit
Durham, North Carolina · Recruiting
The Lysosomal & Rare Disorders Research & Treatment Center
Fairfax, Virginia · Recruiting
SphinCS GmbH
Höchheim, Germany · Recruiting
Erasmus Medical Center
Rotterdam, Netherlands · Recruiting
Royal Free Hospital NHS Trust
London, United Kingdom · Recruiting
Salford Care Organisation Northern Care Alliance NHS Group
Manchester, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.